These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 20059780
1. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. Berchi C, Guittet L, Bouvier V, Launoy G. Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780 [Abstract] [Full Text] [Related]
2. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test. Lejeune C, Dancourt V, Arveux P, Bonithon-Kopp C, Faivre J. Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779 [Abstract] [Full Text] [Related]
3. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [Abstract] [Full Text] [Related]
4. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV. J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475 [Abstract] [Full Text] [Related]
5. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G. Gut; 2007 Feb 03; 56(2):210-4. PubMed ID: 16891354 [Abstract] [Full Text] [Related]
14. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Berchi C, Bouvier V, Réaud JM, Launoy G. Health Econ; 2004 Mar 03; 13(3):227-38. PubMed ID: 14981648 [Abstract] [Full Text] [Related]
15. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Eur J Cancer; 2008 Oct 03; 44(15):2254-8. PubMed ID: 18760592 [Abstract] [Full Text] [Related]
18. Cost effectiveness and projected national impact of colorectal cancer screening in France. Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G. Endoscopy; 2011 Sep 03; 43(9):780-93. PubMed ID: 21623557 [Abstract] [Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y. Am J Gastroenterol; 2005 Nov 03; 100(11):2519-25. PubMed ID: 16279909 [Abstract] [Full Text] [Related]
20. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Sakaguchi K, Shiratori Y. Am J Gastroenterol; 2007 Oct 03; 102(10):2259-64. PubMed ID: 17617203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]